Holmusk is on a mission to harness real-world evidence to transform both research and care for behavioral health. Combining a leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation. Holmusk’s offerings include MindLinc, a behavioral health electronic health record that enables better data collection and improved measurement-based care informed by real-world data, and NeuroBlu, a powerful data analytics platform that leverages natural language processing and predictive disease models to draw new insights. Holmusk is headquartered in Singapore and New York, with five additional offices around the world. For more information, please visit www.holmusk.com.